Renal impairment in chronic cigarette smokers

Journal of the American Society of Nephrology

Volumn 9, Issue 4, 1998, Pages 562-567

  Gambaro, Giovanni ^a   Verlato, Fabio ^a   Budakovic, Alessandro ^a   Casara, Dario ^a   Saladini, Giorgio ^a   Del Prete, Dorella ^a   Bertaglia, Giselda ^a   Masiero, Maurizio ^a   Checchetto, Simone ^a   Baggio, Bruno ^a,b  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b Istituto di Medicina Interna di Padova   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MERTIATIDE TC 99M; PENTETATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; AGING; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY OBSTRUCTION; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; SCINTIGRAPHY;

EID: 0031901725     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Report of the Surgeon General: The health consequences of smoking: Cardiovascular disease. Washington D.C., U.S. Department of Health and Human Services, Office on Smoking and Health, Public Health Service, 1983, Publication no. 84-50204
2. Salonen TJ, Salonen R: Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 87[Suppl 11: 56-65, 1993
3. Cryer PE, Haymond MW, Santiago JV, Shah SD: Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 295: 573-577, 1976
4. Ross R: The pathogenesis of atherosclerosis: Perspective for the 1990s. Nature 362: 801-809, 1993
5. Franek E, Benk U, Reinbold F, Fliser D, Clorius J, Ritz E: Acute influence of smoking on renal function [Abstract]. Nephrol Dial Transplant 11: A65, 1996
6. Muhlauser I: Cigarette smoking and diabetes: An update. Diabetic Med 11: 336-341, 1994
7. Crouse RJ III, Thompson JC: An evaluation of methods for imaging and quantifying coronary and carotid lumen stenosis and atherosclerosis. Circulation 87[Suppl 2]: 17-33, 1993
8. Knox RA, Breslau PJ, Strandness DE Jr: A simple spectral parameter for accurate classification of severe carotid artery disease. Br J Surg 69: 230-233, 1982
9. Kohler TR, Nance DR, Cramer MM, Vandenburghe N, Strandness DE Jr: Duplex scanning for diagnosis of aortoiliac and femoropopliteal disease: A prospective study. Circulation 76: 1074-1080, 1987
10. Gates GF: Glomerular filtration rate: Estimation from fractional renal accumulation of 99mTc-DPTA(stannous). Am J Radiol 138: 565-570, 1982
11. 3 in humans. J Nucl Med 31: 1285-1293, 1990
12. 99mTc renal tubular function agent. Semin Nucl Med 22: 61-73, 1992
13. 3, a comparison with Iodine-123 and Iodine-131 Orthoiodohippurate, in patients with renal disorders. J Nucl Med 29: 147-158, 1988
14. Nally JV, Chen C, Fine E, Fommei E, Ghione S, Geyskes GG, Hoffer PB, Sfakianakis G: Diagnostic criteria for renovascular hypertension with captopril renography: A consensus statement. Am J Hypertens 4: 749S-752S, 1991
15. Blann AD, McCollum CN: Adverse influence of cigarette smoking on the endothelium. Thromb Haemostasis 70: 707-711, 1993
16. Goerre S, Staehli C, Shaw S, Luscher TF: Effect of cigarette smoking and nicotine on plasma endothelin-1 levels. J Cardiovasc Pharmacol 26[Suppl 3]: S236-S238, 1995
17. Luke RG: Nephrosclerosis. In: Disease of the Kidney, edited by Schrier RW, Gottschalk CW, 4th Ed., Boston, Little Brown and Co., 1988, p 1436
18. Celermajer DS, Adams MR, Clarkson BSP, Robinson BSJ, McCredie RNR, Donald A, Deanfield JE: Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 334: 150-154, 1996
19. Nadler JL, Velasco JS, Horton R: Cigarette smoking inhibits prostacyclin formation. Lancet 1: 1248-1250, 1983
20. Wennmalm A, Bethin G, Grastrom EF, Persson L, Petersson AS, Winell S: Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men. Circulation 83: 1698-1704, 1991
21. Nitenberg A, Antony I, Foult JM: Acetylcholine-induced coronary vasoconstriction in young heavy smokers with normal coronary arteriographic findings. Am J Med 95: 71-77, 1993
22. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J, Deanfield JE: Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 88: 2149-2155, 1993
23. Kiowski W, Linder L, Stoschitzky K, Pfistere M, Burckhardt D, Burkart F, Buhler FR: Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation 90: 27-34, 1994
24. Haak T, Jungmann E, Raab C, Usadel KH: Elevated endothelin-1 levels after cigarette smoking. Metabolism 43: 267-269, 1994
25. Kohan DE: Endothelins in the kidney: Physiology and pathophysiology. Am J Kidney Dis 22: 493-510, 1993
26. King AJ, Brenner BM, Anderson S: Endothelin: A potent renal and systemic vasoconstrictor peptide. Am J Physiol 256: F1051-F1058, 1989
27. Lerman A, Hildebrand FL, Aarhus LL, Burnett J: Endothelin has biological actions at pathophysiological concentrations. Circulation 83: 1808-1814, 1991
28. Haynes GW, Webb DJ: The endothelin family of peptides: Local hormones with diverse roles in health and disease? Clin Sci 84: 485-500, 1993
29. Black HR, Zeevi GR, Silten RM, Smith GJW: Effect of heavy igarette smoking on renal and myocardial arterioles. Nephron 34: 173-179, 1983
30. Oberai B, Adams CWM, High OB: Myocardial and renal arteriolar thickening in cigarette smoking. Atherosclerosis 52: 185-190, 1984
31. Ferri C, Bellini C, De Angelis C, De Siati L, Perrone A, Properzi G, Santucci A: Circulating endothelin-1 concentrations in patients with chronic hypoxia. J Clin Pathol 48: 519-524, 1995